Cargando…
Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma
Immunotherapy is now being routinely used in the management of many cancers. It is therefore vital that all clinicians are aware of the diverse array of cutaneous manifestations that can result from their use, which can vary from mild to life threatening.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170966/ https://www.ncbi.nlm.nih.gov/pubmed/30302265 http://dx.doi.org/10.1177/2054270418793029 |
_version_ | 1783360714369400832 |
---|---|
author | Hanley, T Papa, S Saha, M |
author_facet | Hanley, T Papa, S Saha, M |
author_sort | Hanley, T |
collection | PubMed |
description | Immunotherapy is now being routinely used in the management of many cancers. It is therefore vital that all clinicians are aware of the diverse array of cutaneous manifestations that can result from their use, which can vary from mild to life threatening. |
format | Online Article Text |
id | pubmed-6170966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-61709662018-10-09 Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma Hanley, T Papa, S Saha, M JRSM Open Case Report Immunotherapy is now being routinely used in the management of many cancers. It is therefore vital that all clinicians are aware of the diverse array of cutaneous manifestations that can result from their use, which can vary from mild to life threatening. SAGE Publications 2018-10-03 /pmc/articles/PMC6170966/ /pubmed/30302265 http://dx.doi.org/10.1177/2054270418793029 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Hanley, T Papa, S Saha, M Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma |
title | Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma |
title_full | Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma |
title_fullStr | Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma |
title_full_unstemmed | Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma |
title_short | Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma |
title_sort | bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170966/ https://www.ncbi.nlm.nih.gov/pubmed/30302265 http://dx.doi.org/10.1177/2054270418793029 |
work_keys_str_mv | AT hanleyt bullouspemphigoidassociatedwithipilimumabtherapyforadvancedmetastaticmelanoma AT papas bullouspemphigoidassociatedwithipilimumabtherapyforadvancedmetastaticmelanoma AT saham bullouspemphigoidassociatedwithipilimumabtherapyforadvancedmetastaticmelanoma |